Systemic Lupus erythematosus: Biological Effects of Iberdomide

被引:0
|
作者
Brudermanns, Britta
机构
关键词
D O I
10.1055/a-1950-2783
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemischen Lupus erythematodes (SLE) wird durch Gene der Immunresponse-Signalwege und dem Major Histocompatibility Complex Klasse I und II beeinflusst. Iberdomid ist ein hochaffiner Cereblon-Ligand, der den proteasomalen Abbau der Transkriptionsfaktoren Ikaros (IKZF1) und Aiolos (IKZF3) fordert. P. E. Lipsky und Kollegen untersuchten nun die Pharmakodynamik und Pharmakokinetik von oral verabreichtem Iberdomid bei Patienten mit SLE.
引用
收藏
页码:100 / 100
页数:1
相关论文
共 50 条
  • [1] Biological impact of iberdomide in patients with active systemic lupus erythematosus
    Lipsky, Peter E.
    Van Vollenhoven, Ronald
    Doerner, Thomas
    Werth, Victoria P.
    Merrill, Joan T.
    Furie, Richard
    Petronijevic, Milan
    Zamora, Benito Velasco
    Majdan, Maria
    Irazoque-Palazuelos, Fedra
    Terbrueggen, Robert
    Delev, Nikolay
    Weiswasser, Michael
    Korish, Shimon
    Stern, Mark
    Hersey, Sarah
    Ye, Ying
    Gaudy, Allison
    Liu, Zhaohui
    Gagnon, Robert
    Tang, Shaojun
    Schafer, Peter H.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (08) : 1136 - 1142
  • [2] Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus
    Merrill, Joan T.
    Werth, Victoria P.
    Furie, Richard
    van Vollenhoven, Ronald
    Dorner, Thomas
    Petronijevic, Milan
    Velasco, Jorge
    Majdan, Maria
    Irazoque-Palazuelos, Fedra
    Weiswasser, Michael
    Korish, Shimon
    Ye, Ying
    Gaudy, Allison
    Schafer, Peter H.
    Liu, Zhaohui
    Agafonova, Nataliya
    Delev, Nikolay
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (11): : 1034 - 1045
  • [3] Iberdomide - against Aiolos and Ikaros in systemic Lupus erythematosus
    Mucke, Johanna
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2022, 81 (07): : 608 - 609
  • [4] Biological therapies in systemic lupus erythematosus
    Suszek, Dorota
    Jeleniewicz, Radoslaw
    Majdan, Maria
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2012, 66 : 568 - 573
  • [5] Biological therapies in systemic lupus erythematosus
    Cairoli, Ernesto
    Espinosa, Gerard
    Cervera, Ricard
    REVISTA MEDICA DE CHILE, 2010, 138 (07) : 881 - 887
  • [6] Biological treatments for systemic lupus erythematosus
    Isenberg, D
    Leckie, MJ
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2002, 31 (04) : 187 - 191
  • [7] Biological Therapy in Systemic Lupus Erythematosus
    Postal, Mariana
    Costallat, Lilian T. L.
    Appenzeller, Simone
    INTERNATIONAL JOURNAL OF RHEUMATOLOGY, 2012, 2012
  • [8] Emerging biological therapies in systemic lupus erythematosus
    Mount, G. R.
    Gilliland, W. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (01) : 167 - 171
  • [9] Biological causes of depression in Systemic Lupus Erythematosus
    Braga, J.
    Campar, A.
    ACTA REUMATOLOGICA PORTUGUESA, 2014, 39 (03): : 218 - 226
  • [10] BIOLOGICAL DIAGNOSIS OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    BONVOISIN, B
    BOUVIER, M
    SEMAINE DES HOPITAUX, 1983, 59 (15): : 1198 - 1203